IRADIMED CORPORATION Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
IRADIMED CORPORATION (IRMD) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $198.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-03-06
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $198.00K.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $406.00K; Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost as first filed $406.03K.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $163.08K.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $227.68K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost as first filed |
|---|---|---|
| 2025-12-31 | $198.00K 10-K · filed 2026-03-06 | |
| 2024-12-31 | $406.00K 10-K · filed 2026-03-06 | $406.03K 10-K · filed 2025-03-06 |
| 2023-12-31 | $163.08K 10-K/A · filed 2025-09-03 | |
| 2022-12-31 | $227.68K 10-K · filed 2024-03-01 | |
| 2021-12-31 | $208.15K 10-K · filed 2023-03-02 | |
| 2020-12-31 | $491.69K 10-K · filed 2022-03-04 | |
| 2019-12-31 | $790.36K 10-K · filed 2021-03-05 | |
| 2018-12-31 | $927.28K 10-K · filed 2020-03-06 | |
| 2017-12-31 | $985.26K 10-K · filed 2019-03-07 | |
| 2016-12-31 | $1.11M 10-K · filed 2018-03-08 | |
| 2015-12-31 | $427.13K 10-K · filed 2017-03-10 | |
| 2014-12-31 | $417.96K 10-K · filed 2016-03-10 | |
| 2013-12-31 | $152.91K 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |